Get directions
My saved places
MapQuest Travel
Route Planner
Print your map
Get help
Search the web
Send feedback
Learn more about our
mobile apps.
Enterprise solutions
Claim your business
Developer resources
Jobs
Advertise with us
Terms of use
Privacy policy
Data and licenses
About our ads
Do not sell
Advertisement
Advertisement
Search places or paste a link
Hotels
Food
Shopping
Coffee
Grocery
Gas
Schering-Plough Corp
Permanently closed
Save
Call
Website
Share
Directions
Advertisement
Advertisement
2015 Galloping Hill Rd
Kenilworth, NJ 07033
+1 (908) 620-1038
http://schering-plough.com
Also at this address
Greaves, Wayne, Lamar, MD
Haverty, Thomas P MD
Waskin, Hetty MD
Merck and Co Inc
Own this business?
Claim it
See a problem?
Let us know
You might also like
Commercial research laboratory, Surgical instruments and apparatus, Drugs and drug proprietaries
Celsis Laboratory Group-Leberco Division
Celsis Laboratory Group-Leberco Div, based in Edison, NJ, specializes in providing a range of laboratory services to various industries. The company focuses on delivering accurate and timely testing and analysis solutions to meet the needs of its clients. Generated from their business information
Drugs and drug proprietaries, Internal medicine practitioners, Biological research
Irx Therapeutics, Inc
BTX, a subsidiary of Irx Therapeutics in New York, is dedicated to improving the lives of patients and families facing high unmet medical needs by providing access to innovative and effective treatments. The company's mission is to create a world where individuals in need can receive the care and support necessary to address their health challenges, fostering hope and progress in the medical field. Generated from their website's infomation
Drugs and drug proprietaries, Biological research
Azur Rx Bio Pharmer
First Wave BioPharma is a clinical stage biopharmaceutical company based in Brooklyn, NY, specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Their product portfolio includes capeserod, a selective 5-HT4 receptor partial agonist, adrulipase, a recombinant lipase enzyme, and niclosamide, an oral small molecule with anti-inflammatory properties. With a focus on GI-disease programs, First Wave BioPharma aims to address various clinical indications, ranging from nutritional disorders to diseases caused by immune malfunction. Their targets include patient populations with digestive disorders, such as exocrine pancreatic insufficiency and inflammatory bowel diseases like ulcerative colitis and Crohn's disease.Generated from the website
United States
›
New Jersey
›
Kenilworth
›
Schering-Plough Corp
Advertisement
Advertisement